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ABSTRACT 
 
Background: In the scheme of National Health Insurance System, hospital must adapt to the  
newer financial system by regularly doing quality and cost assurance. Stroke, a catasthrophic 
disease, has a high financial impact on hospital cost. This study aimed to examine the determinants 
of cost differences between Indonesian Case Based Groups (INA-CBGs) dan hospital tariff for 
stroke patients in UNS Teaching Hospital, Sukoharjo. 
Subjects and Method: An analytic observation was perfomed in this study from April to May 
2019 by with used the cross sectional design. Recruitment of 113 stroke patients was determined 
using a fixed disease sampling. The dependent variable was cost difference. The independent 
variables were length of stay, intensive care use, medicine tariff, severity level, and type of class 
treatment. The data were obtained from hospital medical record and analyzed by path analysis. 
Results: Medicine tariff was the strongest factor that influenced the difference of tariff (r=-0.65; 
p<0.001). Medicine tariff (b= -3.57; 95% CI= -4.34 to -2.80; p<0.001) and type of class treatment 
(b= 1508.70; 95% CI= 247.54 to 2769.87; p= 0.019) were directly influenced the difference of tariff. 
Length of stay (b= 122.18; 95% CI= 89.52 to 154.84; p<0.001), intensive care use (b= 1161.50; 95% 
CI= 844.01 to 1478.99; p<0.001), severity level (b= 375.58; 95% CI= 143.27 to 607.90; p= 0.002) 
positively influenced the difference of tariff through medicine tariff. Severity level also influenced 
medicine tariff (b=375.58), length of stay (b=1.55), and intensive care use (b=0.16). 
Conclusion: The UNS Hospital cost for stroke patients exceeds the INA-CBGs tariff, which is 
influenced by medicine tariff and intensive care use. 
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RESULTS 
Every year, 150 million people encounter a 
financial problem because they have to  pay 
theirhealth care, which is not covered by 
any health insurance (Xu et al., 2007). In 
Indonesia, health care payment from out-
of-pocket reached 45.3% in 2012 (Trisnan-
toro et al., 2014). Therefore, this problem 
can lead to limitation of health access ser-
vices. Based on the third program of Sus-
tainable Development Goals (SDGs), every-
one has the same right to accesshealth care 
through Universal Health Coverage (UHC).  
Indonesia has implemented the UHC 
by establishment of a National Health Insu-
rance System (NHIS) or Jaminan Kesehat-
an Nasional (JKN), which was launched on 
January 1, 2014. For financial claims, the 
Sosial Security Agency for Health (SSAH) 
or Badan Penyelenggara Jaminan Sosial 
Wulandari et al./ Cost differences between INA-CBGs and hospital tariffs 
e-ISSN: 2549-0281   177 
(BPJS) handles this system. Before the 
NHIS era, some health insurance such as 
ASKES for government employeesprovide 
health care, and they have to pay financial 
claims by fee for services.  
On the other hand, in this NHIS era 
the financial claims are paid by prospective 
payment (Indonesia Case-Based Groups, 
INA-CBGs). Consequently, every Indone-
sian hospital should have quality and cost 
assurance to address to the newer payment 
method. Catasthropic diseases like heart 
diseases and stroke have high financial 
impacts to hospital. Especially, stroke has 
become attention because the hospital cost 
often exceeds the INA-CBGs (Hadning et 
al., 2015; Muslimah et al., 2017; Feladita et 
al., 2014). Evers (2002) states that patients 
with stroke require more hospital re-
sources, due to high levels of morbidity and 
mortality, prolonged treatment, intensive 
care use, and long-term healing conditions, 
compared to other patients without stroke. 
This study therefore aimed to analyze fac-
tors that influenced the differences between 
hospital tariff and INA-CBGs tariff for 
stroke patients in UNS teaching hospital. 
 
SUBJECTS AND METHOD 
1. Study Design 
This analytic study with cross sectional 
design was conducted in UNS Teaching 
Hospital, Sukoharjo, from April to May 
2019. 
2. Population and Samples 
This research study involved 113 stroke 
patients. Those patients were selected using 
the fixed disease sampling and met criteria: 
had national insurance (BPJS), admitted in 
UNS Teaching Hospital between Januari 
and November 2018, and had first attack of 
stroke. They excluded from this study if 
reffered to other hospitals, were refferal 
from other hospitals, and did not continue 
the stroke treatment. 
3. Study Variables 
Independent variables were intensive care 
use, length of stay, medicine tariff, severity 
disease level, and medical ward class, 
whereas the dependent variable was the 
difference between INA-CBGs and hospital 
tariff. All data were collected using medical 
record and billing of selected patients. 
4. Study Variables 
Independent variables were intensive care 
use, length of stay, drugs tariff, severity 
disease level, and medical wardclass, 
whereas the dependent variable was the 
difference between INA-CBGs and hospital 
tariff.All data were collected using medical 
record and billing of selected patients. 
5. Data Analysis 
Univariate and multivariate analysiswere 
used to analyze all collected data. For 
univariate analysis, data were presented as 
number, percentage, and mean. The path 
analysis was run on Stata 13 to examine 
direct and indirect relationships between 
independentand dependent variables. 
6. Research Ethics 
The protocol of this study has been 
approved by The Ethical Committee of 
Medical Research, Faculty of Medicine, 
Universitas Sebelas Maret Surakarta.  
 
RESULTS 
1. Sample Characteristics  
As can be seen from Table 1, the gender 
proportion of study subjects was similar 
between female and male. The majority 
among study subjects aged 46-65 years old 
and had ischemic stroke. Around 60% 
study subjects used the non-Government 
NHIS. After becoming in ward patients, the 
average of medicine tariff was almost one 
million and the length of stay of stroke 
patients ranged from 1 to 16 days. There-
fore, the UNS hospital had to subsidize 
hospital cost around IDR 1,949,440 for 
every stroke patient. 
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From Table 1, a half of stroke patients 
occupied class 3 that was the cheapest 
room. Mild stroke was found in 67.26% 
patients who were admitted in to the 
UNSHospital so that they did not need 
intensive  care use. 
Table 1. sample Characteristicsof  
Characteristics n % Mean + SD Min - Max 
Gender 
Male 
Female 
Age 
26-45 years 
46-65 years 
>65 years 
Type of Stroke 
   Ischemic 
   Hemorrhage 
   Unspecified 
Type of NHIS 
Government 
Non-Government  
Difference of tariff (x IDR 
1,000) 
 
56 
57 
 
11 
56 
47 
 
88 
23 
2 
 
44 
69 
 
49.56 
  50.44 
 
9.65 
49.12 
41.23 
 
77.88 
20.35 
1.77 
 
38.94 
61.06 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-1949.44 + 
4484.96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22806.50 -
7287.29 
Length of stay (day)   7.09 + 3.28 1 - 16 
Medicine tariff (x IDR 1,000)    716.90 + 831.83 76.61 - 4803.72 
Type of Class     
   Class 1 31 27.43   
   Class 2 25 22.12   
   Class 3 57 50.44   
Level of severity     
   Mild 76 67.26   
   Moderate 20 17.70   
   Severe 17 15.04   
Intensive Care Use     
   Yes 15 13.27   
   No 98 86.73   
 
2. Bivariate Analysis 
Results of the Pearson correlation test were 
presented in Table 3. There were different 
relationships among independent variables 
with difference of tariff.  
Table 2. The results of bivariate analysis 
Independent Variables r p 
Medicine Tariff -0.70 < 0.001 
Length of Stay -0.65 < 0.001 
Type of Class 0.13 0.1443 
Intensive Care Use -0.43 < 0.001 
Severity Level -0.15 0.0926 
 
Strong and negative relationships 
were observed in medicine tariff (r=-0.70) 
and length of stay (r=-0.65) to the diffe-
rence of tariff and they reached signifi-
cantly with p<0.001.  
Moreover, intensive care use was 
moderately related to the difference of tariff 
(r= -0.43; p<0.001). In contrast, type of 
class (r= 0.13) and severity level (r= -0.15) 
were weakly related to the difference of 
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tariff and it was not statistically significant 
(p=0.14 and p=0.09 respectively). 
3. Path Analysis 
Path analysis model in this study was 
depicted in Figure 1. Medicine tariff directly 
influenced difference of tariff and was 
affected by intensive care use and length of 
stay. Severity level and type of class became 
exogenous variables for difference of tariff. 
The result of path analysis was then 
described in Table 3. Medicine tariff (b=-
3.57; 95% CI= -4.34 to -2.80; p<0.001) and 
type of class (b= 1508.70; 95% CI= 247.54 
to 2769.87; p=0.019) directly and nega-
tively influenced the difference of tariff. 
However, medicine tariff (β=-0.65) had 
stronger influence than type of class 
(β=0.47) in terms of the difference of tariff.  
Figure 1. A Structural Model of Independent Variables 
and the Dependent Variable 
 
Table 3. The results of path analysis  
Dependent 
Variable 
 
Independent 
Variable 
b β 
 (95%) CI 
p  Lower 
 Limit 
Upper 
Limit 
Direct Effect        
Difference of Tariff  Medicine Tariff -3.57 -0.65 -4.34 -2.80 <0.001 
  Intensive Care 
Use 
-1685.53 -0.12 -3558.57 187.51 0.078 
  Type of Class 1508.70 0.47 247.54 2769.87 0.019 
Indirect Effect        
MedicineTariff  Length of Stay 122.18 0.48 89.52 154.84 <0.001 
  Intensive Care 
Use 
1161.50 0.47 844.01 1478.99 <0.001 
  Severity Level 375.58 0.21 143.27 607.90 0.002 
Length of Stay  Intensive Care 
Use 
-1.52 -0.15 -3.29 0.24 0.092 
  Severity Level 1.55 -0.22 0.27 2.83 0.017 
Intensive Care Use  Severity Level 0.16 0.08 0.03 0.29 0.013 
n Observasi= 113        
Log Likelihood= -2411.22      
b* = unstandardized path coefficient      
β** = standardized path coefficient      
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In addition, intensive care use directly 
influenced the difference of tariff but it was 
not statistically significant (p=0.078). 
Length of stay (b= 122.18; 95% CI= 89.52 
to 154.84; p<0.001), intensive care use (b= 
1161.50; 95% CI= 844.01 to 1478.99; 
p<0.001), severity level (b= 375.58; 95% 
CI= 143.27 to 607.90; p= 0.002) influenced 
the difference of tariff through medicine 
tariff. Severity level influenced length of 
stay (b= 1.55; 95% CI= 0.27 to 2.83; p= 
0.017) and intensive care use (b= 0.16; 95% 
CI= 0.03 to 0.29; p= 0.013), that finally 
contributed to the medicine tariff. 
 
DISCUSSION 
In this present study, we have documented 
that medicine tariff is a stronger factor that 
directly  influences to the difference of tariff 
in stroke patients, compared to type of 
class. Length of stay, intensive care unit, 
and severity level are other important 
factors that contribute to the medicine 
tariff. Meanwhile, severity level increases 
length of stay and intensive care use in 
stroke patients. 
Our finding indicates that increase of 
IDR 1,000  medicine tariff will increase  
IDR 3,570 hospital loss for one stroke 
patient in the UNS Teaching Hospital. 
However, medicine tariff just has 10% 
contribution to total hospital cost. Other 
factors that have higher contribution to the 
difference of tariff are nursing care, medical 
rehabilitation, length of stay, and labora-
tory and radiology examinations (unshown 
data). This study was in line with a study by 
Buisman et al., (2015) and Tuet al., (2003). 
They state that nursingcare is the highest 
factor affecting hospital cost. 
Patients with stroke who occupy class 
3, the UNS Hospital has profit IDR 
1,508,700. By subtracting with medicine 
tariff, the Hospital still has profit from 
stroke patients. However, any patient who 
used the intensive care use, the UNS 
Hospital got loss IDR 1,685,530. From this 
case, the UNS Hospital consequently has 
deficit around IDR 180,000. Based on the 
result of path analysis, the intensive care 
use is not significant to influence the diffe-
rence of tariff because only 13.27% patients 
with stroke used facilities of intensive care 
room. 
The finance loss of UNS Hospital due 
to taking care of stroke patients is in 
accordance to previous studies conducted 
by Hadning et al., (2015); Muslimah et al., 
(2017); and Feladita et al., (2014). They 
found that hospital cost for stroke patients 
was higher than INA-CBGs tariff. More-
over, medicine costs from prescribed drugs 
and medical equipment uses are the highest 
proportion contributing to hospital cost for 
stroke patients (Hadning et al., 2015). In 
contrast to the earlier study, nursing care 
including room and length of stay utility is 
the highest cost for stroke patients (Mus-
limah et al., 2017; Feladita et al., 2014). 
Another finding in this present study 
is that severity level of stroke directly 
affects intensive care use. It is not surprised 
that severe condition of patients with stroke 
definitely require more intensive care and 
use medical equipments (Nordin et al., 
2012). For example, the UNS Hospital will 
spend much more money to take care 
stroke patients because they get further 
treatment of their underlying diseases such 
as hypertension and diabetes mellitus. 
In conclusion, overall the UNS Hos-
pital provides extra money to cover the 
difference of tariff with INA-CBGs tariff, 
which is directly influenced by medicine 
tariff and type of class. To minimize finance 
deficit from stroke patients, drugs uses 
should follow the national standard for 
stroke treatment. 
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